These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 23791464

  • 1. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
    Görgün D, Seçik F, Midilli K, Akkaya V, Yıldız P.
    Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Wen X, Li Y, Meng QH.
    Clin Chim Acta; 2013 Jun 05; 421():230-5. PubMed ID: 23523589
    [Abstract] [Full Text] [Related]

  • 4. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R.
    Respirology; 2004 Mar 05; 9(1):66-9. PubMed ID: 14982604
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.
    Yildiz PB, Yazar EE, Gorgun D, Secik F, Cakir G.
    Asian Pac J Cancer Prev; 2011 Mar 05; 12(2):419-23. PubMed ID: 21545206
    [Abstract] [Full Text] [Related]

  • 7. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
    Liao ND, Chiang TA, Lee WY.
    Cancer Cytopathol; 2013 Dec 05; 121(12):695-702. PubMed ID: 23861325
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
    Gao J, Song L, Li D, Peng L, Ding H.
    Medicine (Baltimore); 2019 Oct 05; 98(42):e17416. PubMed ID: 31626097
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
    Al-Aarag AH, Kamel MH, Abdelgawad ER, Abo-Youssef SM, Moussa HH, Elnaggar ME, Hendy RM, Diab KA.
    BMC Pulm Med; 2019 Jun 25; 19(1):114. PubMed ID: 31238901
    [Abstract] [Full Text] [Related]

  • 15. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
    Pan X, Xing Y, Shi M, Zhou T, Qian B, Chen Y.
    Zhonghua Yi Xue Za Zhi; 2014 May 27; 94(20):1543-6. PubMed ID: 25146741
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC, Corhay JL, Hubin L, Nguyen D, Henket M, Louis R.
    Respir Med; 2008 Dec 27; 102(12):1708-14. PubMed ID: 18760578
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
    Lu GJ, Shao CJ, Zhang Y, Wei YY, Xie WP, Kong H.
    Oncotarget; 2017 Jul 25; 8(30):49217-49223. PubMed ID: 28514746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.